We are live on ! Find out more
AGRX

Agile Therapeutics
AGRX

Delisted

AGRX was delisted on the 25th of March, 2024.

Back to rankings

51 hedge funds and large institutions have $147M invested in Agile Therapeutics in 2015 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 10 increasing their positions, 8 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

280% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 5

38% more funds holding

Funds holding: 37 → 51 (+14)

25% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 8

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

4% less capital invested

Capital invested by funds: $154M → $147M (-$6.26M)

Holders
51
Holders Change
+14
Holders Change %
+37.84%
% of All Funds
1.37%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
19
Increased
10
Reduced
8
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Invesco
Invesco
Georgia
+$6.83M
2
BFA
BlackRock Fund Advisors
California
+$2.67M
3
BIT
BlackRock Institutional Trust
California
+$832K
4
State Street
State Street
Massachusetts
+$640K
5
OM
Opaleye Management
Massachusetts
+$597K

Top Sellers

Rank Fund Capital Flow
1
FCMI
Foresite Capital Management II
California
-$4.37M
2
RA
Royce & Associates
New York
-$1.69M
3
SCM
Sio Capital Management
New York
-$1.52M
4
DM
Deerfield Management
New York
-$973K
5
RJA
Raymond James & Associates
Florida
-$253K
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
26
Renaissance Technologies
New York
$390K +$64K +3 +15%
TCIM
27
TIAA CREF Investment Management
New York
$383K +$469K +22 New
BIM
28
BlackRock Investment Management
Delaware
$317K +$363K +17 +1,700%
Bank of New York Mellon
29
Bank of New York Mellon
New York
$272K +$341K +16 New
RFC
30
Russell Frank Company
Washington
$254K +$320K +15 New
HCMT
31
Highland Capital Management (Texas)
Texas
$243K -$107K -5 -26%
Morgan Stanley
32
Morgan Stanley
New York
$200K -$128K -6 -33%
Northern Trust
33
Northern Trust
Illinois
$179K +$64K +3 +43%
California State Teachers Retirement System (CalSTRS)
34
California State Teachers Retirement System (CalSTRS)
California
$163K +$213K +10 New
CC
35
Caxton Corporation
New Jersey
$151K -$85.4K -4 -31%
TA
36
Teachers Advisors
New York
$128K +$149K +7 New
Charles Schwab
37
Charles Schwab
California
$116K +$149K +7 New
BG
38
BlackRock Group
United Kingdom
$91K +$107K +5 New
MC
39
Menta Capital
California
$87K +$107K +5 New
CI
40
Cowen Inc
New York
$86K +$107K +5 New
Deutsche Bank
41
Deutsche Bank
Germany
$65K – – –
NFA
42
Nationwide Fund Advisors
Ohio
$56K +$64K +3 New
AIG
43
American International Group
New York
$52.4K +$64K +3 New
Royal Bank of Canada
44
Royal Bank of Canada
Ontario, Canada
$48K +$21.3K +1 +50%
BA
45
BlackRock Advisors
Delaware
$44K +$64K +3 New
New York State Common Retirement Fund
46
New York State Common Retirement Fund
New York
$43K +$64K +3 New
SO
47
STRS Ohio
Ohio
$28K +$42.7K +2 New
LTFS
48
Ladenburg Thalmann Financial Services
Florida
$21K – – –
UBS Group
49
UBS Group
Switzerland
$19K – – –
Wells Fargo
50
Wells Fargo
California
$17K – – –
1
2
3

AGRX Hedge Fund Activity: Q2 2015 in Review

51 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Agile Therapeutics (AGRX) for Q2 2015, worth a combined $147M — down 4.1% from $154M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new AGRX positions and 5 closed out — a net gain of 14 holders — while 10 added to existing stakes and 8 trimmed.

The largest buyer was Invesco, opening a new position worth an estimated $6.83M. The largest seller was Foresite Capital Management II, cutting an estimated $4.37M.

  • 51 institutional investors held Agile Therapeutics (AGRX) as of Q2 2015, up from 37 in Q1 2015.
  • Funds reported $147M of Agile Therapeutics stock for Q2 2015, down 4.1% quarter-over-quarter.
  • 19 funds opened new Agile Therapeutics positions in Q2 2015 and 5 closed out, a net change of +14 holders.
  • The largest Agile Therapeutics buyer in Q2 2015 was Invesco, an estimated $6.83M added.
  • The largest Agile Therapeutics seller in Q2 2015 was Foresite Capital Management II, an estimated $4.37M sold.

Based on aggregated 13F filings for Q2 2015.